Your session is about to expire
← Back to Search
Light Therapy
Bright light therapy for Parkinson's Disease
N/A
Waitlist Available
Led By Aleksandar Videnovic, MD, MSc
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
Study Summary
This study is evaluating whether bright light therapy may help improve sleep and alertness for individuals with Parkinson's disease.
Eligible Conditions
- Parkinson's Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Parkinson's Disease Sleep Scale (PDSS-2) score to measure sleep quality
Secondary outcome measures
Epworth Sleepiness Scale (ESS) score to measure daytime sleepiness
Non-Motor Symptoms Assessment Scale for Parkinson's Disease (NMSS) score to measure the severity and frequency of non-motor symptoms
Plasma melatonin levels collected through blood samples to measure melatonin amplitude and circadian regulation
Trial Design
2Treatment groups
Active Control
Group I: Bright light therapyActive Control1 Intervention
Participants will be treated twice daily with bright light therapy.
Group II: Dim-Red light therapyActive Control1 Intervention
Participants will be treated twice daily with dim-red light therapy.
Find a Location
Who is running the clinical trial?
Massachusetts General HospitalLead Sponsor
2,928 Previous Clinical Trials
13,198,290 Total Patients Enrolled
Aleksandar Videnovic, MD, MSc5.02 ReviewsPrincipal Investigator - Massachusetts General Hospital
Massachusetts General Hospital
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger